Omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis

被引：0
|
作者：
Camilo Martinez-Alonso, Jose [1 ]
机构：
[1] Complejo Asistencial Zamora, Unidad Alergol, Zamora, Spain
来源：
REVISTA DE LA SOCIEDAD OTORRINOLARINGOLOGICA DE CASTILLA Y LEON CANTABRIA Y LA RIOJA | 2015年 / 6卷
关键词：
Omalizumab; Nasal Polyps; nasal; sinusitis; rhinitis;
D O I：
暂无
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Introduction and objective: Omalizumab is indicated only in moderate to severe asthma. Bronchial asthma can be associated with nasal polyposis. We reviewed the literature on the effectiveness of omalizumab in the treatment of sinonasal polyposis. Method: Narrative review. Discussion and Conclusions: Omalizumab may be an effective alternative treatment for patients with chronic rhinosinusitis with aggressive polyposis.
引用
收藏
页码：114 / 118
页数：5
相关论文
共 50 条
  • [1] OMALIZUMAB AS A TREATMENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
    Brunet, B. A.
    Marshall, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 636 - 636
  • [2] Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply
    Gevaert, Philippe
    Corren, Jonathan
    Mullol, Joaquim
    Han, Joseph
    Lee, Stella E.
    Ligueros-Saylan, Monica
    Wong, Kit
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (01) : 413 - 414
  • [3] Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis
    Lombardo, Nicola
    Piazzetta, Giovanna Lucia
    Lobello, Nadia
    Cicala, Giuseppe
    Patafi, Maria
    Benincasa, Anna Teresa
    Pelaia, Corrado
    Chiarella, Emanuela
    Pelaia, Girolamo
    Kim, Dong-Kyu
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01):
  • [4] Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis
    Fokkens, Wytske
    van der Lans, Rik
    Reitsma, Sietze
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (05) : 575 - 585
  • [5] Hyaluronan in the Treatment of Chronic Rhinosinusitis with Nasal Polyposis
    Cassandro E.
    Chiarella G.
    Cavaliere M.
    Sequino G.
    Cassandro C.
    Prasad S.C.
    Scarpa A.
    Iemma M.
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2015, 67 (3) : 299 - 307
  • [6] Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis
    Boyle, John V.
    Lam, Kent K.
    Han, Joseph K.
    IMMUNOTHERAPY, 2020, 12 (02) : 111 - 121
  • [7] The role of omalizumab in the treatment of chronic rhinosinusitits with nasal polyposis
    Aldinger, Jeffrey P.
    Dobyns, Taylor
    Lam, Kent
    Han, Joseph K.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1143 - 1149
  • [8] Documentation of biological therapies in chronic rhinosinusitis with nasal polyposis (CRSwNP): dupilumab, omalizumab and mepolizumab
    Klimek, Ludger
    Foerster-Ruhrmann, Ulrike
    Beule, Achim G.
    Chaker, Adam M.
    Hagemann, Jan
    Klimek, Felix
    Casper, Ingrid
    Huppertz, Tilman
    Hoffmann, Thomas K.
    Dazert, Stefan
    Deitmer, Thomas
    Olze, Heidi
    Strieth, Sebastian
    Wrede, Holger
    Schlenter, Wolfgang
    Welkoborsky, Hans-Juergen
    Wollenberg, Barbara
    Bergmann, Christoph
    Cuevas, Mandy
    Beutner, Caroline
    Groeger, Moritz
    Becker, Sven
    ALLERGO JOURNAL, 2022, 31 (06) : 24 - 38
  • [9] Mepolizumab in chronic rhinosinusitis with nasal polyposis
    Liu, Xuandao
    Charn, Tze Choong
    Wang, De-Yun
    IMMUNOTHERAPY, 2023, 15 (14) : 1105 - 1116
  • [10] Refractory Chronic Rhinosinusitis with Nasal Polyposis
    Hull, Benjamin P.
    Chandra, Rakesh K.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2017, 50 (01) : 61 - +
12345